Crossbow Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-30.
Crossbow Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 30, 2025. The filing reports $30.25M sold. Its industry group is Biotechnology. It names Briggs Morrison (Executive Officer, Director, Promoter), Todd Foley (Director), Alexandra Cantley (Director) (SEC Form D, September 30, 2025).
Is this your company?
Sell to companies like Crossbow Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Crossbow Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Crossbow Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in September 2025, largest first.
Get an email when Crossbow Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Crossbow Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Crossbow Therapeutics, Inc. →Get the full cited report on Crossbow Therapeutics, Inc.
What the filing shows about Crossbow Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Crossbow Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Crossbow Therapeutics, Inc.'s address as 1030 Massachusetts Ave, Suite 210, Cambridge, MA 02138.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Crossbow Therapeutics, Inc. See pricing
Crossbow Therapeutics, Inc. is a registered filer with the SEC (CIK 1972912) and has filed since 2023-04-12. 2 filings are on record, the latest on 2025-09-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Crossbow Therapeutics, Inc.'s Form D of 2025-09-30 names Briggs Morrison, Todd Foley, Alexandra Cantley and 6 more as its officers, directors or promoters.
Its new offerings report $67.82M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Briggs Morrison is named as Executive Officer and Director and Promoter on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Todd Foley is named as Director on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Alexandra Cantley is named as Director on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Irena Melnikova is named as Director on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Charles Baum is named as Director on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Sakae Asanuma is named as Director on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Alon Lazarus is named as Director on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Dmitri Wiederschain is named as Executive Officer on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
Alexander Nolte is named as Executive Officer on the Form D that Crossbow Therapeutics, Inc. filed with the SEC on 30 September 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-09-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Crossbow Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Crossbow Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Crossbow Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Crossbow Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Crossbow Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Crossbow Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/crossbow-therapeutics-inc-form-d-25000001